VKTX Stock Eyes Blockbuster Week Despite Share Offering — Retail Traders See A Stronger Hand In Buyout Talks

Shares of Viking Therapeutics (VKTX) are heading for their best weekly run in over two years as promising data for its weight-loss drug VK2735 outweighs, for now, investor unease over a proposed share offering and renewed talks about a possible sale.VKTX stock jumped 36% on Tuesday, its biggest one…